Sneezing and Nasal congestion
A significant decrease in the severity of sneezing was detected upon
comparison of the mean scores before and after injection in the first
three follow-up points. It was 37.5% (p= 0.035) at week 1; 47.5% (p=
0.016) at week 2; and 40% (p= 0.031) at week 4. The values before the
therapy were reached at week 8 (Table.2, Figure.3). Severity of
nasal congestion decreased after injection in the first three follow-up
points but without significant difference. It was 12.5% (p= 0.059) at
week 1; 17.5% (p= 0.071) at week 2; and 7.5% (p= 0.083) at week 4